Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Compreh... by Vaz-Luis, Ines, Ottesen, Rebecca A, Hughes, Melissa E, Marcom, P Kelly, Moy, Beverly, Rugo, Hope S, Theriault, Richard L, Wilson, John, Niland, Joyce C, Weeks, Jane C, Lin, Nancy U

Get full text

Abstract PS17-02: Molecular alterations in the androgen receptor and associated clinical outcomes in hormone receptor-positive/HER2- metastatic breast cancer by Dai, Charles, Niemierko, Andrzej, Vidula, Neelima, Spring, Laura M, Wander, Seth A, Medford, Arielle J, Hesler, Katherine A, Malvarosa, Giuliana, Peppercorn, Jeffrey, Juric, Dejan, Isakoff, Steven J, Moy, Beverly, Ellisen, Leif W, Bardia, Aditya

Get full text

Abstract PD13-09: Impact of neratinib on outcomes in HER2-positive metastatic breast cancer patients with central nervous system disease at baseline: Findings from the phase 3 NALA... by Saura, Cristina, Ryvo, Larisa, Hurvitz, Sara, Gradishar, William, Moy, Beverly, Delaloge, Suzette, Kim, Sung-Bae, Oliveira, Mafalda, Trudeau, Maureen, Dai, Ming-Shen, Haley, Barbara, Bose, Ron, Landeiro, Luciana, Bebchuk, Judith, Frazier, Aimee, Keyvanjah, Kiana, Bryce, Richard, Brufsky, Adam

Get full text

Abstract PS9-02: Neratinib + capecitabine sustains health-related quality of life (HRQoL) while improving progression-free survival (PFS) in patients with HER2+ metastatic breast c... by Moy, Beverly, Oliveira, Mafalda, Saura, Cristina, Gradishar, William, Kim, Sung-Bae, Brufsky, Adam, Hurvitz, Sara, Ryvo, Larisa, Fagnani, Daniele, Chan, Nancy, Kalmadi, Sujith R, Silverman, Paula, Delaloge, Suzette, Bryce, Richard, Keyvanjah, Kiana, Bebchuk, Judith, Zhang, Bo, Oestreicher, Nina, Bose, Ron

Get full text

Implementation of social needs screening for minoritized patients newly diagnosed with breast cancer: a mixed methods evaluation in a pragmatic patient navigation trial by Lemon, Stephenie C, LeClair, Amy M, Christenson, Erika, Amburgey, Deborah, FitzGerald, Madyson, Cabral, Howard, Lloyd-Travaglini, Chris, Clark, Cheryl R, Wang, Feng Qing, Ross, Joellen, Ohrenberger, Ellen, Haas, Jennifer S, Freund, Karen N, Battaglia, Tracy A

Get full text

Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial) by Bellon, Jennifer R., Guo, Hao, Barry, William T., Dang, Chau T., Yardley, Denise A., Moy, Beverly, Marcom, P. Kelly, Albain, Kathy S., Rugo, Hope S., Ellis, Matthew, Wolff, Antonio C., Carey, Lisa A., Overmoyer, Beth A., Partridge, Ann H., Hudis, Clifford A., Krop, Ian, Burstein, Harold J., Winer, Eric P., Tolaney, Sara M.

Get full text

A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry by Smith, Barbara L., Nguyen, Anvy, Korotkin, Jenna E., Kelly, Bridget N., Specht, Michelle C., Spring, Laura M., Moy, Beverly, Isakoff, Steven J., Gadd, Michele A.

Get full text

Patient Navigator Programs, Cancer Disparities, and the Patient Protection and Affordable Care Act by Moy, Beverly, Chabner, Bruce A.

Get full text

Abstract P1-18-22: AKT inhibition in combination with endocrine therapy and a CDK4/6 inhibitor (CDK4/6i) in patients with hormone receptor positive (HR+)/HER2 negative metastatic b... by Wander, Seth A., Micalizzi, Douglas S., Dubash, Taronish, Juric, Dejan, Spring, Laura M., Vidula, Neelima, Keenan, Jennifer, Beeler, Maureen, Viscosi, Elene, Che, Dante, Fisher, Elizabeth L., Hepp, Rachel A., Moy, Beverly, Isakoff, Steven J., Ellisen, Leif W., Supko, Jeffrey G., Maheswaran, Shyamala, Haber, Daniel A., Bardia, Aditya

Get full text

Abstract P3-23-02: Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer receiving CDK 4/6 inhibitors by Denault, Elyssa, Nakajima, Erika, Naranbhai, Vivek, Balazs, Alejandro, Mortensen, Lindsey, Niehoff, Elizabeth, Barabell, Caroline, Hutchinson, Jennifer A., Wander, Seth A., Rosenstock, Aron S., Ellisen, Leif W., Moy, Beverly, Isakoff, Steven J., Gainor, Justin F., Iafrate, A. John, Bardia, Aditya, Spring, Laura M.

Get full text

Abstract PO-077: Impact of COVID-19 on patient navigation for cancer treatment by Percac-Lima, Sanja, Warner, Erica T., Whited, Emma C., Irwin, Kelly E., Navarrete, Aileen, Benjamin, Carmen, Pichardo, Ausubel R., Friese, Christopher R., Ford, Colleen, Wheeler, Amy E., Morrill, James, Moy, Beverly

Get full text

Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer by Vidula, Neelima, Dubash, Taronish, Lawrence, Michael S, Simoneau, Antoine, Niemierko, Andrzej, Blouch, Erica, Nagy, Becky, Roh, Whijae, Chirn, Brian, Reeves, Brittany A, Malvarosa, Giuliana, Lennerz, Jochen, Isakoff, Steven J, Juric, Dejan, Micalizzi, Douglas, Wander, Seth, Spring, Laura, Moy, Beverly, Shannon, Kristen, Younger, Jerry, Lanman, Richard, Toner, Mehmet, Iafrate, A John, Getz, Gad, Zou, Lee, Ellisen, Leif W, Maheswaran, Shyamala, Haber, Daniel A, Bardia, Aditya

Get full text

Impact of Timing on Measurement of Decision Quality and Shared Decision Making: Longitudinal Cohort Study of Breast Cancer Patients by Sepucha, Karen R., Langford, Aisha T., Belkora, Jeffrey K., Chang, Yuchiao, Moy, Beverly, Partridge, Ann H., Lee, Clara N.

Get full text

Institutional Academic−Industry Relationships by Campbell, Eric G, Weissman, Joel S, Ehringhaus, Susan, Rao, Sowmya R, Moy, Beverly, Feibelmann, Sandra, Goold, Susan Dorr

Get full text

Assessment of patient navigation programs for breast cancer patients across the city of Boston by LeClair, Amy M., Battaglia, Tracy A., Casanova, Nicole L., Haas, Jennifer S., Freund, Karen M., Moy, Beverly, Parsons, Susan K., Ko, Naomi Y., Ross, JoEllen, Ohrenberger, Ellen, Mullikin, Katelyn R., Lemon, Stephenie C.

Get full text

Abstract P5-07-02: Factors associated with rapid relapse in triple negative breast cancer: A multi-institution study by Asad, Sarah, Barcenas, Carlos H., Bleicher, Richard J., Cohen, Adam L., Javid, Sara H., Levine, Ellis G., Lin, Nancy U., Moy, Beverly, Niland, Joyce, Wolff, Antonio C., Hassett, Michael J., Stover, Daniel G.

Get full text

Abstract P4-09-06: Brain metastases (BM) in patients with metastatic breast cancer (MBC) and circulating cell-free DNA (cfDNA) somatic BRCA mutations by Vidula, Neelima, Niemierko, Andrzej, Malvarosa, Giuliana, Brastianos, Priscilla, Blouch, Erica, Shannon, Kristen, Isakoff, Steven, Wander, Seth, Spring, Laura, Younger, Jerry, Price, Kristin, Moy, Beverly, Juric, Dejan, Ellisen, Leif, Bardia, Aditya

Get full text

Abstract OT2-08-01: A phase 1b trial to evaluate safety and anti-tumor activity of the AKT inhibitor, ipatasertib, in combination with endocrine therapy with/without CDK 4/6 inhibi... by Wander, Seth A., Juric, Dejan, Spring, Laura M., Vidula, Neelima, Beeler, Maureen, Habin, Karleen, Viscosi, Elene, Scarpetti, Lauren, Tripp, Elizabeth, Hepp, Rachel, Moy, Beverly, Isakoff, Steven J., Ellisen, Leif W., Bardia, Aditya

Get full text

Abstract 1439: Pathological complete response after neoadjuvant chemotherapy predicts improved survival in all major subtypes of breast cancer: systematic review and meta-analyses... by Spring, Laura, Greenup, Rachel, Reynolds, Kerry, Smith, Barbara L., Moy, Beverly, Bardia, Aditya

Get full text

The Elimination of Cancer Health Disparities: Are We Ready to Do the Heavy Lifting? by Jackson, Jonathan D., Moy, Beverly, Evans, Michele K.

Get full text